The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia
Anggia Prasetyoputri,
Anik B. Dharmayanthi,
Syam B. Iryanto,
Ade Andriani,
Isa Nuryana,
Andri Wardiana,
Asep M. Ridwanuloh,
Sri Swasthikawati,
Hariyatun Hariyatun,
Herjuno A. Nugroho,
Idris Idris,
Indriawati Indriawati,
Zahra Noviana,
Listiana Oktavia,
Yuliawati Yuliawati,
Masrukhin Masrukhin,
Erwin F. Hasrianda,
Linda Sukmarini,
Fahrurrozi Fahrurrozi,
Nova Dilla Yanthi,
Alfi T. Fathurahman,
Ari S. Wulandari,
Ruby Setiawan,
Syaiful Rizal,
Ahmad Fathoni,
Wien Kusharyoto,
Puspita Lisdiyanti,
Ratih A. Ningrum,
Sugiyono Saputra
Affiliations
Anggia Prasetyoputri
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Anik B. Dharmayanthi
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Syam B. Iryanto
Research Center for Informatics, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Ade Andriani
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Isa Nuryana
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Andri Wardiana
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Asep M. Ridwanuloh
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Sri Swasthikawati
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Hariyatun Hariyatun
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Herjuno A. Nugroho
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Idris Idris
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Indriawati Indriawati
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Zahra Noviana
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Listiana Oktavia
Research Center for Chemistry, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Yuliawati Yuliawati
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Masrukhin Masrukhin
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Erwin F. Hasrianda
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Linda Sukmarini
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Fahrurrozi Fahrurrozi
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Nova Dilla Yanthi
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Alfi T. Fathurahman
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Ari S. Wulandari
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Ruby Setiawan
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Syaiful Rizal
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Ahmad Fathoni
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Wien Kusharyoto
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Puspita Lisdiyanti
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Ratih A. Ningrum
Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Sugiyono Saputra
Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia
Background Indonesia is one of the Southeast Asian countries with high case numbers of COVID-19 with up to 4.2 million confirmed cases by 29 October 2021. Understanding the genome of SARS-CoV-2 is crucial for delivering public health intervention as certain variants may have different attributes that can potentially affect their transmissibility, as well as the performance of diagnostics, vaccines, and therapeutics. Objectives We aimed to investigate the dynamics of circulating SARS-CoV-2 variants over a 15-month period in Bogor and its surrounding areas in correlation with the first and second wave of COVID-19 in Indonesia. Methods Nasopharyngeal and oropharyngeal swab samples collected from suspected patients from Bogor, Jakarta and Tangerang were confirmed for SARS-CoV-2 infection with RT-PCR. RNA samples of those confirmed patients were subjected to whole genome sequencing using the ARTIC Network protocol and sequencer platform from Oxford Nanopore Technologies (ONT). Results We successfully identified 16 lineages and six clades out of 202 samples (male n = 116, female n = 86). Genome analysis revealed that Indonesian lineage B.1.466.2 dominated during the first wave (n = 48, 23.8%) while Delta variants (AY.23, AY.24, AY.39, AY.42, AY.43 dan AY.79) were dominant during the second wave (n = 53, 26.2%) following the highest number of confirmed cases in Indonesia. In the spike protein gene, S_D614G and S_P681R changes were dominant in both B.1.466.2 and Delta variants, while N439K was only observed in B.1.466.2 (n = 44) and B.1.470 (n = 1). Additionally, the S_T19R, S_E156G, S_F157del, S_R158del, S_L452R, S_T478K, S_D950N and S_V1264L changes were only detected in Delta variants, consistent with those changes being characteristic of Delta variants in general. Conclusions We demonstrated a shift in SARS-CoV-2 variants from the first wave of COVID-19 to Delta variants in the second wave, during which the number of confirmed cases surpassed those in the first wave of COVID-19 pandemic. Higher proportion of unique mutations detected in Delta variants compared to the first wave variants indicated potential mutational effects on viral transmissibility that correlated with a higher incidence of confirmed cases. Genomic surveillance of circulating variants, especially those with higher transmissibility, should be continuously conducted to rapidly inform decision making and support outbreak preparedness, prevention, and public health response.